Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial
Clicks: 321
ID: 120502
2003
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
71.3
/100
321 views
253 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #16 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract. The efficacy and safety of high-dose intravenous polyspecific immunoglobulin G (IVIG) as adjunctive therapy in streptococcal toxic shock syndrome (ST
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (21 words).
Try re-searching for a better abstract.
| Reference Key |
jessica2003clinicalintravenous
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Darenberg, Jessica;Ihendyane, Nahla;Sjölin, Jan;Aufwerber, Ewa;Haidl, Sven;Follin, Per;Andersson, Jan;Norrby-Teglund, Anna;The Streptlg Study Group; |
| Journal | clinical infectious diseases |
| Year | 2003 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.